1.A Case of Friedreich's Ataxia with Optic Atrophy as an Initial Clinical Manifestation.
Ji Hoe HEO ; Oh Young BANG ; Jun Shik MOON ; Il Nam SUNWOO ; Tai Seung KIM
Journal of the Korean Neurological Association 1994;12(3):562-565
The incidence and the nature of visual involvement in Friedreich's ataxia who showed progressive visual impairment a few years before developing characteristic clinical manifestations of Friedreich's ataxia. The progress of disease in this case suggests that visual involvement may be from the same pathogenetic mechanism of peripheral nervous system in Friedreich's ataxia.
Friedreich Ataxia*
;
Incidence
;
Optic Atrophy*
;
Peripheral Nervous System
;
Vision Disorders
2.A Case of Early Onset Cerebellar Ataxia with Retained Tendon Reflexes.
Jong Bum LEE ; Hae Yong LEE ; Jae Seung YANG ; Baek Keun LIM
Journal of the Korean Pediatric Society 1997;40(1):129-133
Early onset cerebellar ataxia with retained tendon reflexes is clinical syndrome characterized by progressive cerebelar ataxia of unknown etiology with an onset within the first two decades. This disorder was distinguished from Friedreich's ataxia by the preservation of the tendon reflexes. We have experienced a case of early onset cerebellar ataxia with retained tendon reflexes which was diagnosed by clinical features, eletrophysiologic studies, and MRI scan. This 8 year-old male patient had suffered from gait ataxia with delayed growth and development since 3 years of age. A brief review of the related literatures was also made.
Ataxia
;
Cerebellar Ataxia
;
Child
;
Friedreich Ataxia
;
Gait Ataxia
;
Growth and Development
;
Humans
;
Magnetic Resonance Imaging
;
Male
;
Reflex, Stretch*
;
Spinocerebellar Degenerations*
;
Tendons*
3.A Case of Early Onset Cerebellar Ataxia with Retained Tendon Reflexes.
Jong Bum LEE ; Hae Yong LEE ; Jae Seung YANG ; Baek Keun LIM
Journal of the Korean Pediatric Society 1997;40(1):129-133
Early onset cerebellar ataxia with retained tendon reflexes is clinical syndrome characterized by progressive cerebelar ataxia of unknown etiology with an onset within the first two decades. This disorder was distinguished from Friedreich's ataxia by the preservation of the tendon reflexes. We have experienced a case of early onset cerebellar ataxia with retained tendon reflexes which was diagnosed by clinical features, eletrophysiologic studies, and MRI scan. This 8 year-old male patient had suffered from gait ataxia with delayed growth and development since 3 years of age. A brief review of the related literatures was also made.
Ataxia
;
Cerebellar Ataxia
;
Child
;
Friedreich Ataxia
;
Gait Ataxia
;
Growth and Development
;
Humans
;
Magnetic Resonance Imaging
;
Male
;
Reflex, Stretch*
;
Spinocerebellar Degenerations*
;
Tendons*
4.Early Onset Cerebellar Ataxia with Retained Tendon Reflexes Developed in Brothers: Report of two cases.
Jeong Mee PARK ; Tae Il PARK ; Roh Wook PARK
Journal of the Korean Academy of Rehabilitation Medicine 1997;21(2):461-
Early onset cerebellar ataxia with retained tendon reflexes is distinctive clinical syndrome characterized by progressive cerebellar ataxia of unknown etiology with an onset within the first two decades. This disorder was distinguished from Friedreich's ataxia by the preservation of the deep tendon reflexes. There is 22-year-old male with 13 year history of slowly progressive cerebellar ataxia and dysarthria. His elder brother, also, has milder clinical manifestations, electrophysiological and radiological abnormalities. We experienced two cases of early onset cerebellar ataxia with retained tendon reflexes developed in brothers which was diagnosed by clinical manifestations, electrophysiologic, radiologic studies and report with brief review of related literatures.
Cerebellar Ataxia
;
Dysarthria
;
Friedreich Ataxia
;
Humans
;
Male
;
Reflex, Stretch*
;
Siblings*
;
Spinocerebellar Degenerations*
;
Tendons*
;
Young Adult
5.The Etiologies of Chronic Progressive Cerebellar Ataxia in a Korean Population.
Ji Sun KIM ; Soonwook KWON ; Chang Seok KI ; Jinyoung YOUN ; Jin Whan CHO
Journal of Clinical Neurology 2018;14(3):374-380
BACKGROUND AND PURPOSE: The etiologies and frequencies of cerebellar ataxias vary between countries. Our primary aim was to determine the frequency of each diagnostic group of cerebellar ataxia patients in a Korean population. METHODS: We reviewed the medical records of patients who were being followed up between November 1994 and February 2016. We divided patients with cerebellar ataxias into familial and non-familial groups and analyzed the frequency of each etiology. Finally, we categorized patients into genetic, sporadic, secondary, and suspected genetic, but undetermined ataxia. RESULTS: A total of 820 patients were included in the study, among whom 136 (16.6%) familial patients and 684 (83.4%) non-familial cases were identified. Genetic diagnoses confirmed 98/136 (72%) familial and 72/684 (11%) nonfamilial patients. The overall etiologies of progressive ataxias comprised 170 (20.7%) genetic, 516 (62.9%) sporadic, 43 (5.2%) secondary, and 91 (11.1%) undetermined ataxia. The most common cause of ataxia was multiple-system atrophy (57.3%). In the genetic group, the most common etiology was spinocerebellar ataxia (152/170, 89.4%) and the most common subtype was spinocerebellar ataxia-3.38 of 136 familial and 53 of 684 sporadic cases (91/820, 11.1%) were undetermined ataxia. CONCLUSIONS: This is the largest epidemiological study to analyze the frequencies of various cerebellar ataxias in a Korean population based on the large database of a tertiary hospital movement-disorders clinic in South Korea. These data would be helpful for clinicians in constructing diagnostic strategies and counseling for patients with cerebellar ataxias.
Ataxia
;
Atrophy
;
Cerebellar Ataxia*
;
Counseling
;
Diagnosis
;
Epidemiologic Studies
;
Friedreich Ataxia
;
Humans
;
Korea
;
Medical Records
;
Spinocerebellar Ataxias
;
Tertiary Care Centers
6.Drosophila models for studying iron-related neurodegenerative diseases.
Zhou-Jing ZHU ; Ka-Chun WU ; Zhong-Ming QIAN ; Wing-Ho YUNG ; Ya KE
Acta Physiologica Sinica 2014;66(1):47-54
In recent years, iron has been regarded as a common pathological feature of many neurodegenerative diseases, including Alzheimer's disease (AD), Parkinson's disease (PD) and Friedreich's ataxia (FRDA). A number of genes involved in iron transport, storage and regulation have been found associated with initiation and progression of neurodegeneration. However, whether iron abnormalities represent a primary or secondary event still remains unknown. Due to the limitation in transgenic rodent model construction and transfection systems, the progress in unraveling the pathogenic role of different iron-related proteins in neurodegenerative diseases has been slow. Drosophila melanogaster, a simple organism which has a shorter lifespan and smaller genome with many conserved genes, and captures many features of human nervous system and neurodegeneration, may help speed up the progress. The characteristics that spatial- and temporal-specific transgenic Drosophila can be easily constructed and raised in large quantity with phenotype easily determined turn Drosophila into an excellent in vivo genetic system for screening iron-related modifiers in different neurodegenerative conditions and hence provide a better picture about the pathogenic contribution of different iron-related protein abnormalities. It is believed that identification of important iron-related genes that can largely stop or even reverse degenerative process in Drosophila models may lead to development of novel therapeutic strategies against neurodegenerative diseases.
Alzheimer Disease
;
physiopathology
;
Animals
;
Disease Models, Animal
;
Drosophila melanogaster
;
Friedreich Ataxia
;
physiopathology
;
Humans
;
Iron
;
Neurodegenerative Diseases
;
physiopathology
;
Parkinson Disease
;
physiopathology
7.Electrophysiological Studies in a Case of Friedreich's Ataxia.
Sang Am LEE ; Il Nam SUNWOO ; Ki Whan KIM
Journal of the Korean Neurological Association 1986;4(1):137-141
Observing a 16 years old male of classical Friedreich's ataxia with progressive ataxia, dysarthria, areflexia, loss of vibration and proprioception, Babinski sign, pes cavus, scoliosis, hyperglycemia, optic atrophy and hearing deficits, the nerve conduction studies and several evoked potential studies are performed. The sensory nerve potentials are markedly decreased in amplitude and the average technique has to be used to get the potentials, worse distally. The motor nerve functions, however, are normal. There is no consistent waves recorded on BAEP even with maximal stimulation bilaterally. VEP reveals prolonged latencies bilaterally but with normal amplitudes. On median nerve SEP stimulated at wrist, the amplitudes of potentials at Erb's point look decreased and no definite evoked potentials are recored at contralateral scalp. In contrast, the cervical evoked potentials are normal in amplitudes and latencies.
Adolescent
;
Ataxia
;
Dysarthria
;
Evoked Potentials
;
Foot Deformities
;
Friedreich Ataxia*
;
Hearing
;
Humans
;
Hyperglycemia
;
Male
;
Median Nerve
;
Neural Conduction
;
Optic Atrophy
;
Proprioception
;
Reflex, Babinski
;
Scalp
;
Scoliosis
;
Vibration
;
Wrist
8.Application of Iron Related Magnetic Resonance Imaging in the Neurological Disorders.
Tae Hyoung KIM ; Jae Hyeok LEE
Korean Journal of Clinical Neurophysiology 2014;16(1):1-7
Iron is an important element for brain oxygen transport, myelination, DNA synthesis and neurotransmission. However, excessive iron can generate reactive oxygen species and contribute neurotoxicity. Although brain iron deposition is the natural process with normal aging, excessive iron accumulation is also observed in various neurological disorders such as neurodegeneration with brain iron accumulation, Parkinson's disease, Alzheimer's disease, multiple sclerosis, Friedreich ataxia, and others. Magnetic resonance image (MRI) is a useful method for detecting iron deposits in the brain. It can be a powerful tool for diagnosis and monitoring, while furthering our understanding of the role of iron in the pathophysiology of a disease. In this review, we will introduce the mechanism of iron toxicity and the basics of several iron-related MRI techniques. Also, we will summarize the previous results concerning the clinical application of such MR imagings in various neurological disorders.
Aging
;
Alzheimer Disease
;
Brain
;
Diagnosis
;
DNA
;
Friedreich Ataxia
;
Iron*
;
Magnetic Resonance Imaging*
;
Multiple Sclerosis
;
Myelin Sheath
;
Nervous System Diseases*
;
Neurodegenerative Diseases
;
Oxygen
;
Parkinson Disease
;
Reactive Oxygen Species
;
Synaptic Transmission
9.Safety and Biodistribution of Human Bone Marrow-Derived Mesenchymal Stromal Cells Injected Intrathecally in Non-Obese Diabetic Severe Combined Immunodefi ciency Mice: Preclinical Study
Mari Paz QUESADA ; David GARCÍA-BERNAL ; Diego PASTOR ; Alicia ESTIRADO ; Miguel BLANQUER ; Ana Ma GARCÍA-HERNÁNDEZ ; José M MORALEDA ; Salvador MARTÍNEZ
Tissue Engineering and Regenerative Medicine 2019;16(5):525-538
BACKGROUND: Mesenchymal stromal cells (MSCs) have potent immunomodulatory and neuroprotective properties, and have been tested in neurodegenerative diseases resulting in meaningful clinical improvements. Regulatory guidelines specify the need to perform preclinical studies prior any clinical trial, including biodistribution assays and tumourigenesis exclusion. We conducted a preclinical study of human bone marrow MSCs (hBM-MSCs) injected by intrathecal route in Non-Obese Diabetic Severe Combined Immunodeficiency mice, to explore cellular biodistribution and toxicity as a privileged administration method for cell therapy in Friedreich's Ataxia. METHODS: For this purpose, 3 × 10⁵ cells were injected by intrathecal route in 12 animals (experimental group) and the same volume of culture media in 6 animals (control group). Blood samples were collected at 24 h (n = 9) or 4 months (n = 9) to assess toxicity, and nine organs were harvested for histology and safety studies. Genomic DNA was isolated from all tissues, and mouse GAPDH and human β2M and β-actin genes were amplified by qPCR to analyze hBM-MSCs biodistribution. RESULTS: There were no deaths nor acute or chronic toxicity. Hematology, biochemistry and body weight were in the range of normal values in all groups. At 24 h hBM-MSCs were detected in 4/6 spinal cords and 1/6 hearts, and at 4 months in 3/6 hearts and 1/6 brains of transplanted mice. No tumours were found. CONCLUSION: This study demonstrated that intrathecal injection of hBM-MSCs is safe, non toxic and do not produce tumors. These results provide further evidence that hBM-MSCs might be used in a clinical trial in patients with FRDA.
Animals
;
Biochemistry
;
Body Weight
;
Bone Marrow
;
Brain
;
Cell- and Tissue-Based Therapy
;
Culture Media
;
DNA
;
Friedreich Ataxia
;
Heart
;
Hematology
;
Humans
;
Injections, Spinal
;
Mesenchymal Stromal Cells
;
Methods
;
Mice
;
Neurodegenerative Diseases
;
Neuroprotection
;
Reference Values
;
Severe Combined Immunodeficiency
;
Spinal Cord